A medical team from King Abdul Aziz University has succeeded in registering a patent at the United States Patent and Trademark Office, for a new medical nano-based compound that improves the working of the cardiac muscle, after it was successfully tested on experimental animals, and it was determined that the compound is fit for human use.
Vast wealth and the promise of dramatic change make for cautious optimism concerning Saudi Arabia, the chief executive…60 Views | the publication reaches you by | Saudi Arabia Today
Professor Ahmed bin Saeed Azhar, consultant pediatric cardiologist at the Faculty of Medicine at King Abdul Aziz University, a member of the medical team, said that the patent related to the nano-emulsion drug that greatly activate weak heart and blood vessels associated with the food assimilation syndrome.
“We started working on the idea three years ago, and we worked initially on experimental animals and then the last stage was testing the nano-based drug on humans,” professor Azhar said.
“Before we started experiments on animals, animals were made to become overweight and exposed to certain food assimilation diseases to weaken their heart muscle, and increase blood pressure in their arteries. On applying the drug to the animals, we found after several tests, that it improved the cardiac muscle, bettered blood flow and decreased the blood pressure.
Cardiovascular diseases represent the first cause of morbidity in Western countries, and, although in recent years substantial strides have been made in treatment strategies, mortality still remains high.
The project for the design, engineering and procurement of the new 400,000m3/day Jubail II seawater reverse osmosis (SWRO)…68 Views | the publication reaches you by | Saudi Arabia Today
Do you have information you want to reach our readers?